Sleep–related breathing disorders with a focus on obstructive sleep apnoea
Citation
AIHW
Australian Institute of Health and Welfare (2021) Sleep–related breathing disorders with a focus on obstructive sleep apnoea, AIHW, Australian Government, accessed 17 May 2024. doi:10.25816/ae90-x421
APA
Australian Institute of Health and Welfare. (2021). Sleep–related breathing disorders with a focus on obstructive sleep apnoea. Canberra: AIHW. doi:10.25816/ae90-x421
MLA
Australian Institute of Health and Welfare. Sleep–related breathing disorders with a focus on obstructive sleep apnoea. AIHW, 2021. doi:10.25816/ae90-x421
Vancouver
Australian Institute of Health and Welfare. Sleep–related breathing disorders with a focus on obstructive sleep apnoea. Canberra: AIHW; 2021. doi:10.25816/ae90-x421
Harvard
Australian Institute of Health and Welfare 2021, Sleep–related breathing disorders with a focus on obstructive sleep apnoea, AIHW, Canberra. doi:10.25816/ae90-x421
PDF | 11.6Mb
Sleep-related breathing disorders, in particular obstructive sleep apnoea (OSA), can have detrimental effects on sleep-quality and health. Effective diagnosis and successful treatment can reduce symptoms and improve the quality of life of patients. In Australia, eligible patients can access Medicare-funded sleep study services to clinically assess and diagnose sleep disorders, including OSA.
This report provides a profile of people undertaking sleep studies and treatments for sleep disorders with a focus on OSA.
- ISBN: 978-1-76054-862-9
- DOI: 10.25816/ae90-x421
- Cat. no: PHE 294
- Pages: 40
-
Rates were higher for home-based sleep studies (4.7 per 1,000 population) than laboratory sleep studies (2.1)
-
In 2019, 134,481 patients received diagnostic sleep study—6.7 per 1,000 Australians aged 18 and over
-
Claiming rates for sleep studies varied by state and territory, remoteness and socioeconomic area of residence
-
The total Medicare benefits paid for sleep studies was $47 million for diagnostic & $10 million for treatment management